Being Rare Together: Medscape Education Sponsors the 2025 Cholestatic Liver Disease Summit
June 26, 2025 | BeingRareTogether, CLD, CLDSummit, HighHopes, RareDisease, collaboration
Medscape Education is a proud sponsor of the inaugural 2025 Cholestatic Liver Disease Summit, taking place June 26–28 in Aurora, Colorado, at the Hyatt Regency Aurora-Denver Conference Center. Hosted in partnership with Children’s Hospital Colorado, a national leader in cholestatic liver disease treatment and research, this summit represents a powerful step forward for families, clinicians, researchers, and advocates actively working to improve the lives of those affected by rare liver conditions.
This first-of-its-kind event brings together a diverse community focused on rare cholestatic liver diseases. Over three days, the summit will include a Scientific Meeting, Research Roundtable, and a Patient & Family Conference, designed to foster collaboration across disciplines and improve care for rare liver disease communities.
Medscape Education’s sponsorship reflects our deep commitment to supporting underserved and complex disease areas through trusted, evidence-based education. We are especially honored to collaborate with key advocacy organizations, such as the Alagille Syndrome Alliance (ALGSA), Biliary Atresia Research and Education (BARE), and the PFIC Advocacy & Resource Network, Inc., whose efforts continue to drive awareness, research, and hope across these rare conditions.
Rare liver diseases often take 6 to 8 years to be accurately diagnosed. Through education, we aim to help shorten this journey. To support ongoing learning and clinical excellence in rare diseases, we have developed a dedicated learning center for healthcare professionals, created in collaboration with rare disease organizations and leading experts. Our Pathways in Rare Disease initiative is designed to help clinicians recognize the early signs of rare diseases and apply the latest insights in diagnosis and management in clinical practice.
This Summit offers a unique opportunity to bring scientists, clinicians, industry, patients, and families together to bridge knowledge gaps, accelerate research, and build a future of High Hopes for those impacted by cholestatic liver disease. Medscape Education is proud to stand alongside this community as we work together to transform rare disease care through knowledge, compassion, and collaboration.
For more information on this collaboration and future rare disease education, please contact Jennifer Bomberger.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Medscape Education: Rare Diseases
It's only a few days until #RareDiseaseDay2023 on 28th February. We're taking a patient centered approach, this means understanding their journey so we can better understand how we can help to...
Together Caring for Rare Disease
Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...
Medscape Education Wins Best Practice Award for Learner Outcomes at NAMEC
This year's winners have been announced for the National Association of Medical Education Companies (NAMEC) awards. These awards recognize best practices-ideas or processes that can be implemented by NAMEC members to...
Medscape Education and Medics4RareDisease Uncover the Education Gaps in Their Compelling Rare Disease Day Campaign
Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...
What Does Net Promoter Score Offer in the Evaluation of Continuing Medical Education?
Net promoter Score (NPS) has been used in many fields, such as software, clinical care, and websites, as a measure of customer satisfaction since 2003. With a single question, NPS...
DIGITAL HEALTH IN PRACTICE AND OVERCOMING DIGITAL FATIGUE
During this year’s Reuters event, Pharma 2022, WebMD CMO, Dr John Whyte discussed the ways in which digital health is growing, and the importance of educating clinicians in the right...
ESMO’s New Focus on Cancer Prevention
During ESMO 2022 in Paris, John Whyte, chief medical officer at WebMD was joined by Fabrice André, MD, PhD, Chair of the scientific committee at the European Society for Medical Oncology (ESMO),...
ESMO Patient Centricity – Highlights from Steve Clark
During #ESMO22 we brought together a panel of world-renowned experts, including WebMD CMO John Whyte, Professor Nadia Harbeck, MD, PhD, Lesley Fallowfield DBE, and Steve Clark, patient advocate and campaigns ambassador, Cancer Research UK (CRUK),...
ESMO Patient Centricity Highlights from Dr. Whyte
During #ESMO22 we brought together a panel of world-renowned experts, including WebMD CMO John Whyte, Professor Nadia Harbeck, MD, PhD, Lesley Fallowfield DBE, and Steve Clark, patient advocate and campaigns ambassador, Cancer Research UK (CRUK), volunteer...
Closing The Gaps in Patient-Centricity in Cancer Care
Highlights from the Medscape Education full panel discussion during this year's #ESMO22.